1. Introduction {#sec1-ijerph-12-10093}
===============

As a common opportunistic bacterial pathogen of hospital-acquired infections, *Acinetobacter baumannii* has a high ability to acquire resistance to multiple antibiotics and clonal spread \[[@B1-ijerph-12-10093],[@B2-ijerph-12-10093],[@B3-ijerph-12-10093]\]. Multiple-, extensive- or extreme-drug resistant *A. baumannii* is reported worldwide, and the outbreaks of infection with drug resistant strains have become a serious threat to global public health \[[@B4-ijerph-12-10093],[@B5-ijerph-12-10093],[@B6-ijerph-12-10093],[@B7-ijerph-12-10093]\]. Integron is a specific integration and exercise system that allows the capture of a single or multiple exogenous gene cassettes, which is of a great significance in the emergence and spread of multidrug resistant *A. baumannii* (MDRAB) \[[@B8-ijerph-12-10093],[@B9-ijerph-12-10093],[@B10-ijerph-12-10093]\]. A regional variation has been detected in the type and gene cassette structure of integron in MDRAB strains \[[@B11-ijerph-12-10093],[@B12-ijerph-12-10093],[@B13-ijerph-12-10093]\]. Therefore, understanding of the epidemiological features and spread pattern may provide new insights into the management of *A. baumannii* infections and antibiotic resistance \[[@B14-ijerph-12-10093],[@B15-ijerph-12-10093],[@B16-ijerph-12-10093]\]. The major purposes of this multiple-hospital study were to investigate the prevalence of integrons in MDRAB strains isolated from 16 tertiary hospitals in Eastern China, and characterize the integron-integrase genes, in order to provide evidence for the management and appropriate antibiotic use of MDRAB infections.

2. Materials and Methods {#sec2-ijerph-12-10093}
========================

2.1. A. baumannii Isolates {#sec2dot1-ijerph-12-10093}
--------------------------

A total of 514 clinical bacterial isolates, identified as MDRAB using VITEK 2 (bioMérieux; Marcy l'Etoile, France), were collected from 16 tertiary hospitals in 11 cities of four Chinese provinces (Fujian, Jiangsu, Zhejiang and Shandong) during the period from January 2009 through June 2012. Then, a one-tube multiplex PCR assay was performed for rapid identification of *A. baumannii* using the method described previously \[[@B17-ijerph-12-10093]\]. Accordingly, 425 isolates were identified as *A. baumannii* ([Table 1](#ijerph-12-10093-t001){ref-type="table"}), while the other 89 isolates belonged to other species of *Acinetobacter*.

ijerph-12-10093-t001_Table 1

###### 

Number of *A. baumannii* strains isolated from 16 hospitals in eastern China.

  Province   City      Hospital Code   Number of *A. baumannii* Strains Isolated
  ---------- --------- --------------- -------------------------------------------
  Fujian     Fuzhou    A               254
  B          2                         
  C          20                        
  D          15                        
  Xiamen     E         25              
  F          1                         
  G          3                         
  Quanzhou   H         14              
  Longyan    I         5               
  Nanping    J         56              
  Jiangsu    Nanjing   K               3
  Zhejiang   Haining   L               3
  Hangzhou   M         17              
  Taizhou    N         2               
  Wenzhou    O         2               
  Shandong   Yantai    P               3
  Total      425                       

2.2. Antimicrobial Susceptibility Test {#sec2dot2-ijerph-12-10093}
--------------------------------------

The susceptibility of *A. baumannii* to ampicillin/sulbactam, piperacillin/tazobactam, ceftazidime, ceftriaxone, cefepime, aztreonam, meropenem, amikacin, gentamicin, tobramycin, ciprofloxacin, levofloxacin, sulfamethoxazole/trimenthoprim, minocycline (National Institutes for Food and Drug Control, Beijing, China) and imipenem (Merck Sharp & Dohme Pharmaceutical Co., Ltd., Shanghai, China) was tested using the Clinical Laboratory Standard Institute (CLSI) recommended agar dilution method \[[@B18-ijerph-12-10093]\], and was evaluated using the CLSI interpretive criteria \[[@B19-ijerph-12-10093]\]. *Escherichia coli* ATCC25922 and *Pseudomonas aeruginosa* ATCC27853 (Shanghai Fuxiang Biotech Co., Ltd., Shanghai, China) served as quality control bacterial isolates.

2.3. Characterization of Integrons and Their Gene Cassettes {#sec2dot3-ijerph-12-10093}
-----------------------------------------------------------

The bacterial colonies of *A. baumannii* were prepared into bacterial suspensions, boiled at 100 °C for 10 min in a DK-8D thermostatic water bath (Shanghai Boheng Scientific Instruments Co., Ltd., Shanghai, China), and then centrifuged at 8000 r/min for 10 min at room temperature. The supernatant was collected and used as a DNA template for the subsequent PCR assay.

Characterization of class 1 (*intI1*), 2 (*intI2*) and 3 (*intI3*) integron-integrase genes and *intI1* gene cassette (*intI CS*) was done using a PCR assay in a 50 μL system containing 5 μL of 10 × PCR buffer, 1 μL of each forward and reverse primer reported previously ([Table 2](#ijerph-12-10093-t002){ref-type="table"}) \[[@B20-ijerph-12-10093]\], 4 μL of dNTPs (Takara, Dalian, China), 0.3 μL of Taq DNA polymerase (Takara), 5 μL of DNA template, and 33.7 μL of ddH~2~O. The conditions for PCR amplification were: initial denaturation at 95 °C for 5 min, followed by 30 cycles of denaturation at 95 °C for 30 s, primer annealing at 55 °C for *intI1* and *intI2*, 50 °C for *intI3* and 46 °C for *intI CS* for 30 s, and extension at 72 °C for 30 (for *intI1* and *intI2*) or 60 s (for *intI3* and *intI CS*), and final extension at 72 °C for 7 min. The PCR amplification products were checked with electrophoresis on a 1.5% agarose gel. In addition, the variable region of integrons was amplified using the specific primers targeting the 5' and 3' conserved regions, purified, and sequenced by the Shanghai Biosune Biotechnology Co., Ltd. (Shanghai, China). Then, the type and sequence of the gene cassette were identified through homology analysis using the software BLAST \[[@B21-ijerph-12-10093],[@B22-ijerph-12-10093],[@B23-ijerph-12-10093]\].

ijerph-12-10093-t002_Table 2

###### 

Primer sequences and PCR product size of integrase genes.

  Integrase Gene                        Primer Sequences                       PCR Product Size (bp)   Reference
  ------------------------------------- -------------------------------------- ----------------------- -----------
  *intl1*                               F: 5'-CAG TGG ACA TAA GCC TGT TC-3';   160                     20
  R: 5'-CCC GAG GCA TAG ACT GTA-3'                                                                     
  *intl2*                               F: 5'-TTG CGA GTA TCC ATA ACC TG-3';   288                     20
  R: 5'-TTA CCT GCA CTG GAT TAA GC-3'                                                                  
  *intl3*                               F: 5'-GCCTCCGGCAGCGACTTTCAG-3';        1041                    20
  R: 5'-ACGGATCTGCCAAACCTGACT-3'                                                                       
  *intl CS*                             F: 5'-GGC ATC CAA GCA GCA AG-3';       Unknown                 20
  R: 5'-AAGCAG ACT TGA CCT GA-3'                                                                       

2.4. Strain Typing of Integron-Positive A. baumannii Isolates {#sec2dot4-ijerph-12-10093}
-------------------------------------------------------------

The integron-positive *A. baumannii* isolates were genotyped using pulsed-field gel electrophoresis (PFGE) \[[@B24-ijerph-12-10093]\], while *Salmonella* serotype Braenderup H9812 strain (PulseNet China, Beijing, China) served as a standard quality control isolate. Briefly, genomic DNA was extracted from integron-positive *A. baumannii* isolates, and digested with restriction endonuclease *Apa I* (New England Biolabs, Inc., Beverly, MA, USA). Electrophoresis was performed at 14 °C on a 1% Seakem Gold agarose gel (Lonza, Rockland, ME, USA) in the CHEF Mapper® Pulsed Field Electrophoresis System (Bio-Rad, Hercules, CA, USA) for 19 h under the following conditions: switching time of 5 to 20 s, 120° field angle, and voltage of 6 V/cm. Gel images were captured using the Gel Doc XR^+^ imaging system (Bio-Rad), and all PFGE profiles were processed using the software BioNumerics version 6.0 (Applied Maths, Inc., Austin, TX, USA). Similarities were obtained using the Dice coefficient at a 1.5% tolerance, and a dendrogram was constructed with the unweighted-pair group method using average linkages (UPGMA) clustering method. A mean similarity of \<90% indicated various PFGE genotypes, whereas a similarity of 90% or greater was defined as the same PFGE genotype \[[@B24-ijerph-12-10093]\].

2.5. Ethical Statement {#sec2dot5-ijerph-12-10093}
----------------------

This study was approved by the institutional review board of Fujian Medical University Union Hospital and Fujian Medical University. All experimental procedures performed in this study complied with all laws and regulations in China.

2.6. Statistical Analysis {#sec2dot6-ijerph-12-10093}
-------------------------

All antimicrobial susceptibility testing results were analyzed using the software WHONET version 5.6, and all statistical analyses were performed with the statistical software SPSS 14.0 (SPSS Inc., Chicago, IL, USA). The differences of the prevalence of antimicrobial resistance were compared with chi-square test. A *P* value \<0.05 was considered statistically significant.

3. Results {#sec3-ijerph-12-10093}
==========

3.1. Prevalence of intI1, intI2 and intI3 Genes in A. baumannii {#sec3dot1-ijerph-12-10093}
---------------------------------------------------------------

Among the 425 clinical isolates of MDRAB, there were 296 isolates (69.6%) positive for *intI1* gene, while *intI2* and *intI3* genes were not detected ([Figure 1](#ijerph-12-10093-f001){ref-type="fig"}).

![Electrophoresis of the PCR amplification products of *intI1* gene. M, DL 2000 DNA Marker; 1--23, *A. baumannii* isolates; 24, Negative control isolate. Positive bands show the PCR products of *intI1* gene.](ijerph-12-10093-g001){#ijerph-12-10093-f001}

3.2. Comparison of the Prevalence of Antimicrobial Resistance between Integron-Positive and -Negative A. baumannii Isolates {#sec3dot2-ijerph-12-10093}
---------------------------------------------------------------------------------------------------------------------------

A significantly higher prevalence of resistance to ampicillin/sulbactam, piperacillin/tazobactam, ceftazidime, ceftriaxone, cefepime, aztreonam, imipenem, meropenem, amikacin, gentamicin, tobramycin, ciprofloxacin, levofloxacin and sulfamethoxazole/trimenthoprim was detected in integron-positive *A. baumannii* isolates than in integron-negative isolates (all *p* values \<0.05); however, no significant difference was observed in the prevalence of minocycline resistance between these two groups isolates ([Table 3](#ijerph-12-10093-t003){ref-type="table"}).
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###### 

Comparison of the prevalence of antimicrobial resistance between integron-positive and -negative *Acinetobacter baumannii* isolates.

  Antimicrobial                    Integron-Positive *A. baumannii* Isolates (*n* = 296)   Integron-Negative *A. baumannii* Isolates (*n* = 129)   *p* Value
  -------------------------------- ------------------------------------------------------- ------------------------------------------------------- -----------
  Ampicillin/sulbactam             89.9%                                                   62.4%                                                   \<0.05
  Piperacillin/tazobactam          92.7%                                                   65.2%                                                   \<0.05
  Ceftazidime                      98.5%                                                   75.4%                                                   \<0.05
  Ceftriaxone                      100%                                                    98%                                                     \<0.05
  Cefepime                         94.3%                                                   74.6%                                                   \<0.05
  Aztreonam                        99.6%                                                   93.1%                                                   \<0.05
  Imipenem                         86.6%                                                   65.8%                                                   \<0.05
  Meropenem                        89.9%                                                   57.6%                                                   \<0.05
  Amikacin                         87.8%                                                   42.7%                                                   \<0.05
  Gentamicin                       98.1%                                                   71.7%                                                   \<0.05
  Tobramycin                       93.3%                                                   62.7%                                                   \<0.05
  Ciprofloxacin                    98.7%                                                   77.7%                                                   \<0.05
  Levofloxacin                     86.2%                                                   55.4%                                                   \<0.05
  Sulfamethoxazole/trimenthoprim   98.3%                                                   85.3%                                                   \<0.05
  Minocycline                      39.3%                                                   28.8%                                                   0.119

3.3. PFGE Analysis of intI1 Gene-Positive A. baumannii Isolates {#sec3dot3-ijerph-12-10093}
---------------------------------------------------------------

PFGE assay of 296 *intI1* gene-positive *A. baumannii* isolates revealed 27 PFGE genotypes, and there were 4 genotypes containing 10 or more *A. baumannii* isolates, including genotypes P1 (102 isolates), P4 (101 isolates), P7 (25 isolates) and P19 (10 isolates) ([Figure 2](#ijerph-12-10093-f002){ref-type="fig"}).

![PFGE profile of 296 *A. baumannii* isolates positive for *intl1* gene.](ijerph-12-10093-g002){#ijerph-12-10093-f002}

3.4. Distribution of intI1 Gene-Positive A. baumannii Isolates {#sec3dot4-ijerph-12-10093}
--------------------------------------------------------------

The *intI1* gene was detected in the clinical strains of *A. baumannii* isolated from 15 hospitals. The PFGE genotype P1, which contained 102 *A. baumannii* isolates, was detected in the *A. baumannii* strains isolated from hospitals A (48%) and J (43.1%) ([Figure 3](#ijerph-12-10093-f003){ref-type="fig"}). The PFGE genotype P4, which contained 101 *A. baumannii* isolates, was found in the *A. baumannii* strains isolated from four hospitals in two cities ([Figure 4](#ijerph-12-10093-f004){ref-type="fig"}), 96% of which was detected in the *A. baumannii* strains isolated from A hospital. The PFGE genotype P7, which contained 25 *A. baumannii* isolates, was prevalent in the *A. baumannii* strains isolated from four hospitals in three cities ([Figure 5](#ijerph-12-10093-f005){ref-type="fig"}), 64% of which was detected in the *A. baumannii* strains isolated from hospital E. The PFGE genotype P9 contained 10 *A. baumannii* strains, which were isolated from hospitals A (seven isolates), I (two isolates) and D (one isolate).

![Distribution of *A. baumannii* isolates with PFGE genotype P1.](ijerph-12-10093-g003){#ijerph-12-10093-f003}

![Distribution of *A. baumannii* isolates with PFGE genotype P4.](ijerph-12-10093-g004){#ijerph-12-10093-f004}

![Distribution of *A. baumannii* isolates with PFGE genotype P5.](ijerph-12-10093-g005){#ijerph-12-10093-f005}

3.5. Antimicrobial Resistance Pattern of intI1 Gene-Positive A. baumannii Isolates with PFGE Genotypes P1 and P4 {#sec3dot5-ijerph-12-10093}
----------------------------------------------------------------------------------------------------------------

PFGE assay revealed that P1 and P4 were the predominant PFGE genotypes in the 296 *intI1 gene*-positive *A. baumannii* isolates. The PFGE genotype P1 contained 13 extensive-drug resistant and 89 non-extensive-drug resistant *A. baumannii* isolates, and the PFGE genotype P4 contained 34 extensive-drug resistant and 67 non-extensive-drug resistant *A. baumannii* isolates. There were significant differences observed in the antimicrobial resistance pattern (both *p* values \<0.05).

3.6. Sequencing of int I Gene Cassette {#sec3dot6-ijerph-12-10093}
--------------------------------------

The variable region of integrons was detected in 115 *A. baumannii* isolates positive for *intI1* gene, in which two arrays of cassettes, with 2.3 kb (97 isolates) and 1.8 kb (18 isolates) in lengths, were detected. Sequence alignment revealed that the sequences of these two arrays of gene cassettes had both 99% homology with the sequences of the two cassettes (GenBank accession number: AY557339 and AB154407) within the variable regions of class I integron of *A. baumannii*, which encoded the drug resistance gene cassettes *aacA4-catB8-aadA1* and *dfrXII-orfF-aadA2*.

4. Discussion {#sec4-ijerph-12-10093}
=============

The long-term extensive use of antimicrobial agents may lead to the emergence of antimicrobial resistance \[[@B25-ijerph-12-10093]\]. Elucidation of the mechanism underling the antimicrobial resistance would be of great importance for the prevention and control of the spread of drug-resistant bacteria \[[@B26-ijerph-12-10093]\]. Under the selective pressure of antibiotics, MDRAB may emerge due to gene mutations and acquisition of exogenous drug resistance genes \[[@B27-ijerph-12-10093]\]. Horizontal transfer of drug resistance genes may occur within and among bacterial species \[[@B28-ijerph-12-10093]\], and integron-mediated horizontal transfer of drug resistance genes has been paid more and more attention \[[@B29-ijerph-12-10093],[@B30-ijerph-12-10093]\]. It is reported that integrons play a vital role in the horizontal transfer of drug resistance genes in Gram-negative bacilli \[[@B31-ijerph-12-10093]\].

Integrons are classified according to the sequence of the integrase gene. Currently, class 1 and 2 integrons are the most common types detected in Gram-negative bacteria, and class 1 integron shows the highest prevalence in *A. baumannii* \[[@B32-ijerph-12-10093]\]. It has been shown that there are 40%--92% of *A. baumannii* strains carrying class 1 integrons, with a low prevalence of class 2 integrons detected, and class 1 integrons and their gene cassettes are a major contributor to the emergence of MDRAB \[[@B11-ijerph-12-10093],[@B33-ijerph-12-10093],[@B34-ijerph-12-10093]\]. Detection of integrons is therefore considered to serve as an indicator to assess the epidemics of *A. baumannii* \[[@B8-ijerph-12-10093],[@B9-ijerph-12-10093],[@B10-ijerph-12-10093]\]. In the present study, 69.6% of MDRAB isolates were found to carry *intI1* gene, with no *intI2* gene detected, and PFGE assay of the *intI1* gene-positive *A. baumannii* isolates revealed four predominant epidemic clones, including genotypes P1, P4, P7 and P19, which were epidemic in 10 hospitals sampled from seven cities. Since a large number of *A. baumannii* strains were isolated from hospital A during a long period of time, the *intI1* gene-positive *A. baumannii* clinical isolates from hospital A were characterized 14 PFGE genotypes, and a high proportion of P1 and P4 genotypes was detected, notably P4 (96%). In relative to other PFGE genotypes, the clinical *A. baumannii* isolates with P1 genotype were distributed in seven hospitals from five cities. Hospital A is a large tertiary teaching hospital, and critically ill patients throughout Fujian Province are admitted to the hospital, which results in the inter-hospital spread of *intI1* gene-positive MDRAB.

It has been proved that integrons are involved in the development of MDR in *A. baumannii* \[[@B12-ijerph-12-10093],[@B15-ijerph-12-10093],[@B30-ijerph-12-10093]\]. A higher prevalence of antibiotic resistance is detected in integron-positive MDRAB than in negative strains \[[@B34-ijerph-12-10093],[@B35-ijerph-12-10093]\]. Detection of 48 epidemic clinical strains of *A. baumannii* isolated from 11 hospitals showed a 50% carriage of integrons in the tested bacterial strains, and a greater prevalence of MDR was detected in integron-positive strains than in negative strains, demonstrating the important role of integrons in antibiotic resistance and thereby in the epidemic behavior of *A. baumannii* \[[@B36-ijerph-12-10093]\]. Our findings showed a significantly greater prevalence of resistance to ampicillin/sulbactam, piperacillin/tazobactam, ceftazidime, ceftriaxone, cefepime, aztreonam, imipenem, meropenem, amikacin, gentamicin, tobramycin, ciprofloxacin, levofloxacin and sulfamethoxazole/trimenthoprim was detected in integron-positive *A. baumannii* isolates than in negative isolates (all *p* values \<0.05), which was in agreement with previous reports \[[@B34-ijerph-12-10093],[@B35-ijerph-12-10093],[@B36-ijerph-12-10093]\]. In addition, we compared the antimicrobial resistance pattern of P1 and P4 clones, two predominant PFGE genotypes in the 296 *intl1 gene*-positive *A. baumannii* isolates, and significant differences were found (both *p* values \<0.05). The PFGE genotype P4 contained more extensive-drug resistant *A. baumannii* isolates, and this clone was found to be the predominant epidemic genotype in hospital A. Therefore, the strengthening of the implementation of interventions targeting the management of MDRAB infections and appropriate use of antibiotics are required.

The category and number of integron-carried gene cassettes are strongly associated with the development of MDR in *A. baumannii* \[[@B9-ijerph-12-10093],[@B15-ijerph-12-10093]\]. The regional variation of epidemic MDRAB clones leads to various epidemic characteristics of their drug resistance gene cassettes. Among the 65 *A. baumannii* isolates collected from four regional hospitals in northern Taiwan in 2009, approximately 72% carriage of *intI1* genes was detected in the *A. baumannii* isolates, which mainly carried three gene cassette arrays of *aacC1-orfX-orfX-orfX'-aadA1a*, *aacA4-catB8-aadA1* and *dfrXII-orfF-aadA2* \[[@B37-ijerph-12-10093]\]. Detection of class 1 and class 2 integrons in *A. baumannii* isolates from nine hospitals in Turkey showed 6.4% (18/281) prevalence of class 1 integrons and absence of class 2 integrons in the *A. baumannii* isolates, and the gene cassettes of class 1 integrons *AacC1-AAC(3)I-aadA1*, *AacC1-aadA1*, *AAC(3)-I*, *AAC(3)-I-AAC(3)-I-aadA1*, *TEM-1*, *AAC(3)-I-aadA1-AAC(3)-I-AAC(3)-I*, *AAC(3)-I-AAC(3)-I-AAC(3)-I-aadA1*, *AAC(3)-I-aadA1*, *AAC(3)-I- AAC(3)-I*, *AAC(3)-I-aadA1-AAC(3)-I-aadA1* and *AAC(3)-I-AAC(3)-I-aadA1-AAC(3)-I-aadA1* were detected in 18 isolates \[[@B22-ijerph-12-10093]\]. In the United Kingdom, class 1 integrons were found in all of the outbreak isolates of *A. baumannii* but in none of the sporadic isolates, and integrons were recognized as useful markers for the outbreak of epidemic strains of *A. baumannii*; in addition, four integron cassette arrays were reported, including *aacA4*, *aacA4-catB8-aadA1*, *aacC1-orfX-orfX'-aadA1a* and *aacC1-orfX- orfX-orfX'-aadA1a* \[[@B11-ijerph-12-10093]\], which have been found in other outbreak strains of *A. baumannii* from Taiwan \[[@B37-ijerph-12-10093]\], Italia \[[@B38-ijerph-12-10093]\] and some other European countries \[[@B39-ijerph-12-10093]\]. In addition, class 1 integrons were detected 52.8% of the *A. baumannii* isolates collected from Nanjing, China, which mainly carried gene cassette arrays of *orf1-aadA1* and *aacA4-catB8-aadA1*. In the current study, the gene cassette arrays of *aacA4-catB8-aadA1* and *dfrXII-orfF-aadA2* were detected. The *aacA4-catB8-aadA1* is a common gene cassette worldwide; however, *dfrXII-orfF-aadA2* is only epidemic in eastern China \[[@B40-ijerph-12-10093]\]. This is the first report of the gene cassette *dfrXII-orfF-aadA2* in *A. baumannii* strains isolated from Fujian Province, Eastern China. In these two gene cassettes, *aacA4* encodes aminoglycoside 6'-N-acetyltransferase, which results in the resistance to amikacin, netilmicin, and tobramycin; *aadA1* encodes aminoglycoside nucleotidyltransferase, which induces the resistance to streptomycin and spectinomycin; *catB8* encodes chloramphenicol acetyltransferase, which leads to the resistance to chloromycetin; *orfF* is a gene with unknown function; *dhfrXII* is a dihyrofolate reductase gene, which mediates the resistance to trimethoprim and streptomycin; and *aadA2* is a streptomycin adenylyltransferase gene, which is involved in the resistance to streptomycin and spectinomycin. Therefore, the drug resistance genes carried by these two gene cassettes are involved in the development of resistance to aminoglycosides and sulfonamides. However, no drug resistance genes involved in the resistance to carbapenems were detected in these two gene cassettes, inferring the complex mechanisms of antimicrobial resistance in *A. baumannii*.

5. Conclusions {#sec5-ijerph-12-10093}
==============

A high prevalence of class 1 integrons is detected in MDRAB in Eastern China, and the prevalence of antimicrobial resistance is greater in *intI1* gene-positive MDRAB isolates than in negative isolates. There are four predominant PFGE genotypes in *intI1* gene-positive MDRAB isolates, in which P4 is an epidemic PFGE genotype in Fujian Province, and it has a high proportion of extensive drug resistant *A. baumannii*. We report the gene cassette dfrXII-orfF-aadA2, for the first time, in *A. baumannii* strains isolated from Fujian Province, Eastern China.
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